Clinical significance of HER2 overexpression as assessed by immunohistochemistry and fluorescence in situ hybridisation in patients with gastric cancer

被引：0
|
作者：
Im, S. [1 ]
Kim, J. [1 ]
Kim, M. [1 ]
Jordan, B. [2 ]
Oh, D. [1 ]
Lee, H. [1 ]
Yang, H. [1 ]
Kim, V [1 ]
Kim, W. [1 ]
Bang, Y. [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea
[2] Roche Diagnost Ltd, Rotkreuz, Switzerland
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：20 / 21
页数：2
相关论文
共 50 条
  • [1] Comparison of HER2 status by fluorescence in situ hybridisation and immunohistochemistry in gastric cancer
    Ming Chen
    Yan Li
    Zhou Ming
    Ai Biao
    Liu Xue Zheng
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2014, 18 (02): : 95 - 99
  • [2] Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer
    Yano, T
    Doi, T
    Ohtsu, A
    Boku, N
    Hashizume, K
    Nakanishi, M
    Ochiai, A
    ONCOLOGY REPORTS, 2006, 15 (01) : 65 - 71
  • [3] Clinical Significance of HER2/Neu Overexpression in Gastric Cancer
    Barojas, Paola Figueroa
    Alejandra, Zarate Osorno
    Quinonez-Urrego, Enoe E.
    Hernandez-Guerrero, Angelica
    Sobrino-Cossio, Sergio R.
    Alonso-Larraga, Juan Octavio
    GASTROENTEROLOGY, 2010, 138 (05) : S289 - S290
  • [4] Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer
    Liu, Xuechao
    Xu, Pengfei
    Qiu, Haibo
    Liu, Jianjun
    Chen, Shangxiang
    Xu, Dazhi
    Li, Wei
    Zhan, Youqing
    Li, Yuanfang
    Chen, Yingbo
    Zhou, Zhiwei
    Sun, Xiaowei
    ONCOTARGETS AND THERAPY, 2016, 9 : 949 - 958
  • [5] Relationship between HER2 status and proliferation rate in breast cancer assessed by immunohistochemistry, fluorescence in situ hybridisation and standardised AgNOR analysis
    Bánkfalvi, AB
    Giuffè, G
    Öfner, D
    Diallo, R
    Poremba, C
    Buchwalow, IB
    Barresi, V
    Böcker, W
    Tuccari, G
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (05) : 1285 - 1292
  • [6] Her2 Amplification Status in Iranian Breast Cancer Patients: Comparison of Immunohistochemistry (IHC) and Fluorescence in situ Hybridisation (FISH)
    Ghaffari, Saeed Reza
    Sabokbar, Tayebeh
    Dastan, Jila
    Rafati, Maryam
    Moossavi, Shirin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (04) : 1031 - 1034
  • [7] Evaluation of the clinical significance of HER2 amplification by chromogenic in situ hybridisation in patients with primary breast cancer
    Dandachi, N
    Dietze, O
    Hauser-Kronberger, C
    ANTICANCER RESEARCH, 2004, 24 (04) : 2401 - 2406
  • [8] Comparison of immunohistochemistry and chromogenic in situ hybridisation for the determination of HER2 status in breast and gastric cancer.
    Shi, D.
    Zhang, G.
    Liang, X.
    Hou, J.
    Kang, S.
    Zhu, W.
    Chen, L.
    Zhou, Y.
    Li, X.
    Shao, Y.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S51 - S51
  • [9] Assessment of HER2 status in breast cancer by fluorescence in situ hybridisation
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 235 - 236
  • [10] HER2 expression in gastric cancer in Indian population—An immunohistochemistry and fluorescence in situ hybridization study
    Anuradha Sekaran
    Raja Sekhar Kandagaddala
    Santosh Darisetty
    Sandeep Lakhtakia
    Santa Ayyagari
    Guduru Venkat Rao
    Pradeep Rebala
    Duvvuru Bhaskara Reddy
    Duvvuru Nageshwar Reddy
    Indian Journal of Gastroenterology, 2012, 31 (3) : 106 - 110
12345